Table 4.
Univariate Cox proportional‐hazards analysis for risk of a cardiac event
| Item | Hazard ratio | 95% CI | P |
|---|---|---|---|
| Age (per 1 year increase) | 1.03 | 1.00–1.07 | 0.032 |
| Gender male | 0.52 | 0.23–1.20 | 0.12 |
| Body mass index (per 1 kg/m2 increase) | 0.83 | 0.72–0.94 | 0.004 |
| NYHA III or IV (vs. NYHA I or II) | 6.68 | 2.94–14.77 | <0.001 |
| Diabetes mellitus | 1.70 | 0.77–3.78 | 0.18 |
| Hypertension | 1.68 | 0.71–4.62 | 0.24 |
| COPD | 0.91 | 0.21 | 0.88 |
| Systolic blood pressure (per 1 mmHg increase) | 1.00 | 0.98–1.02 | 0.72 |
| Haemoglobin (per 1 g/dL increase) | 0.89 | 0.74–1.07 | 0.24 |
| Platelet count (per 1 × 103/μL increase) | 0.99 | 0.98–1.00 | 0.094 |
| Total bilirubin (per 1 mg/dL increase) | 2.60 | 0.52–10.93 | 0.22 |
| AST (per 1 U/L increase) | 1.01 | 0.98–1.03 | 0.28 |
| ALT (per 1 U/L increase) | 1.00 | 0.98–1.01 | 0.70 |
| GGT (per 1 U/L increase) | 1.00 | 0.99–1.00 | 0.21 |
| Albumin (per 1 g/dL increase) | 0.61 | 0.28–1.30 | 0.20 |
| Sodium (per 1 mmol/L increase) | 0.87 | 0.76–1.00 | 0.060 |
| eGFR (per 10 mL/min/1.73 m2 increase) | 0.86 | 0.72–1.01 | 0.073 |
| ln (NT pro‐BNP) (per 1.0 increase) | 1.34 | 1.02–1.77 | 0.032 |
| Fibrosis‐4 index (per 1.0 increase) | 1.11 | 0.97–1.21 | 0.091 |
| NFS (per 1.0 increase) | 1.12 | 0.92–1.31 | 0.23 |
| LVDd (per 1 mm increase) | 0.97 | 0.93–1.02 | 0.34 |
| LVEF < 40% | 0.43 | 0.14–1.07 | 0.07 |
| LAD (per 1 mm increase) | 0.98 | 0.92–1.02 | 0.41 |
| RVDd (per 1 mm increase) | 1.07 | 1.01–1.12 | 0.047 |
| TRPG (per 1 mmHg increase) | 1.03 | 1.00–1.06 | 0.023 |
| Estimated RAP (per 1 mmHg increase) | 1.09 | 1.01–1.17 | 0.027 |
| MAGGIC risk score (per 1 increase) | 1.09 | 1.02–1.16 | 0.007 |
| Spleen diameter (per 1 mm increase) | 0.96 | 0.93–0.98 | 0.047 |
| Spleen stiffness (per 1 kPa increase) | 1.05 | 1.03–1.07 | <0.001 |